Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;18(10):700-705.
doi: 10.1007/s12519-022-00604-7. Epub 2022 Aug 16.

Frequency and safety of COVID-19 vaccination in children with multisystem inflammatory syndrome: a telephonic interview-based analysis

Kubra Aykac  1 , Kubra Ozturk  2 , Osman Oguz Demir  3 , Dilan Demir Gumus  3 , Sevgi Aslan  4 , Ela Cem  5 , Miray Yilmaz Celebi  5 , Mustafa Dogan Karabacak  5 , Gulsum Alkan  6 , Fatma Dilsad Aksoy  7 , Burcu Ceylan Cura Yayla  8 , Eda Kepenekli  4 , Solmaz Celebi  7 , Melike Emiroglu  6 , Ilker Devrim  5 , Ali Bulent Cengiz  1 , Mehmet Ceyhan  1 , Yasemin Ozsurekci  9
Affiliations

Frequency and safety of COVID-19 vaccination in children with multisystem inflammatory syndrome: a telephonic interview-based analysis

Kubra Aykac et al. World J Pediatr. 2022 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have indicated they have no potential conflicts of interest to disclose.

Figures

Fig. 1
Fig. 1
The number of children included in this study. COVID-19 coronavirus disease 2019, MIS-C multisystem inflammatory syndrome in children, CDC US Center for Disease Control, WHO World Health Organization
Fig. 2
Fig. 2
Vaccine types and the timing of COVID-19 vaccination and MIS-C diagnosis in three children who were vaccinated prior to MIS-C diagnosis. PCR polymerase chain reaction, COVID-19 coronavirus disease 2019, MIS-C multisystem inflammatory syndrome in children, C1D1 case 1 dose 1, C1D2 case 1 dose 2, C2D1 case 2 dose 1, C2D2 case 2 dose 2, C3D1 case 3 dose 1 (the figure was created using Biorender.com)
See this image and copyright information in PMC

References

    1. Zambrano LD, Newhams MM, Olson SM, Halasa NB, Price AM, Boom JA, et al. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12–18 years-United States, July–December 2021. MMWR Morb Mortal Wkly Rep. 2022;71:52–8. doi: 10.15585/mmwr.mm7102e1. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention. Interim clinical considerations for use of COVID-19 vaccines currently approved or authorized in the United States. https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-v.... Accessed 7 Jan 2022.
    1. Centers for Disease Control and Prevention. Emergency preparedness and response: health alert network. https://emergency.cdc.gov/han/2020/han00432.asp. Accessed 10 Nov 2020.
    1. World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19. www.who.int/publications-detail/multisystem-inflammatory-syndrome-in-chi.... Accessed 10 Nov 2020.
    1. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. 2020;145:e20200702. doi: 10.1542/peds.2020-0702. - DOI - PubMed

Substances

Supplementary concepts